Sinofn Health
Sinofn Health
Founded in 2012, SINOFN Health Co., Ltd. stands at the intersection of rigorous scientific research and industrial-scale manufacturing. As a national high-tech enterprise backed by the Chinese Academy of Sciences, we have evolved from a specialized PKU (Phenylketonuria) dietary developer into a premier global OEM/ODM powerhouse.
Our commitment to E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness) is evidenced by our deep clinical integration. Under the leadership of Mrs. GuoHong Liu and our elite team of scientists—including PhDs from Peking University and international experts from the Netherlands—we ensure that every formulation is not just market-viable but clinically validated.
The global market is shifting from "one-size-fits-all" to hyper-personalized supplementation. Consumers demand solutions for specific metabolic markers, sleep optimization, and longevity (NMN/NAD+). SINOFN leverages our R&D center to accelerate "lab-to-market" cycles for these precise formulations.
Modern procurement is no longer just about low cost; it's about Supply Chain Resilience. Our "Factory 4.0" approach integrates IoT, automated GMP production, and blockchain-based traceability. This ensures that global brands receive high-purity, consistent batches with 100% audit transparency, mitigating geopolitical and logistical risks.
State-of-the-Art Facilities
Patents Held
Annual Capacity (Units)
Registered Trademarks
We operate under FSSC 22000, ISO 22000, and HACCP standards. Our facility includes a dedicated R&D and testing center equipped with HPLC and GC-MS contaminant screening, ensuring raw material purity and final product stability for global markets.
Yes. Our pilot-scale prototyping service allows brands to test formulations with minimal risk, optimizing bioavailability and dissolution before scaling to full-plant production runs.
Our competitive advantage lies in our R&D-Led Manufacturing model. Unlike typical contract manufacturers, we provide clinical insights and regulatory expertise, essential for entering complex health markets in Europe, North America, and beyond.
